Literature DB >> 9230920

A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) by ADP-ribose.

T V Zharova1, A D Vinogradov.   

Abstract

Considerable quantitative variations in the competitive inhibition of NADH oxidase activity of bovine heart submitochondrial particles (SMP) by different samples of NAD- were observed. ADP-ribose (ADPR) was identified as the inhibitory contaminating substance responsible for variations in the inhibition observed. ADPR competitively inhibits NADH oxidation with Ki values (25 degrees C, pH 8.0) of 26 microM, 30 microM, and 180 microM for SMP, purified Complex I and three-subunit NADH dehydrogenase (FP), respectively. ADPR decreases NADH-induced flavin reduction and prolongs the cyclic bleaching of FP during aerobic oxidation of NADH. Ki for inhibition of the rotenone-sensitive NADH oxidase in SMP by ADPR does not depend on delta mu H+. The initial rate of the energy-dependent NAD+ reduction by succinate is insensitive to ADPR. The inhibitor increases the steady-state level of NAD+ reduction reached during aerobic succinate-supported reverse electron transfer catalyzed by tightly coupled SMP. The results obtained are consistent with the proposal on different nucleotide-binding sites operating in the direct and reverse reactions catalyzed by the mitochondrial NADH-ubiquinone reductase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230920     DOI: 10.1016/s0005-2728(97)00029-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Kinetics of electron transfer through the respiratory chain.

Authors:  Qusheng Jin; Craig M Bethke
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

2.  Redox-dependent change of nucleotide affinity to the active site of the mammalian complex I.

Authors:  Vera G Grivennikova; Alexander B Kotlyar; Joel S Karliner; Gary Cecchini; Andrei D Vinogradov
Journal:  Biochemistry       Date:  2007-08-31       Impact factor: 3.162

3.  Allosteric nucleotide-binding site in the mitochondrial NADH:ubiquinone oxidoreductase (respiratory complex I).

Authors:  Vera G Grivennikova; Grigory V Gladyshev; Andrei D Vinogradov
Journal:  FEBS Lett       Date:  2011-05-27       Impact factor: 4.124

4.  EPR characterization of ubisemiquinones and iron-sulfur cluster N2, central components of the energy coupling in the NADH-ubiquinone oxidoreductase (complex I) in situ.

Authors:  Sergey Magnitsky; Larisa Toulokhonova; Takahiro Yano; Vladimir D Sled; Cecilia Hägerhäll; Vera G Grivennikova; Doshimjan S Burbaev; Andrei D Vinogradov; Tomoko Ohnishi
Journal:  J Bioenerg Biomembr       Date:  2002-06       Impact factor: 2.945

Review 5.  NADH/NAD+ interaction with NADH: ubiquinone oxidoreductase (complex I).

Authors:  Andrei D Vinogradov
Journal:  Biochim Biophys Acta       Date:  2008-04-18

Review 6.  Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Chris Cadonic; Mohammad Golam Sabbir; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2015-11-04       Impact factor: 5.590

7.  Hydrolase regulates NAD+ metabolites and modulates cellular redox.

Authors:  Lei Tong; Susan Lee; John M Denu
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

8.  Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer.

Authors:  Kenneth R Pryde; Judy Hirst
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

9.  Investigation of NADH binding, hydride transfer, and NAD(+) dissociation during NADH oxidation by mitochondrial complex I using modified nicotinamide nucleotides.

Authors:  James A Birrell; Judy Hirst
Journal:  Biochemistry       Date:  2013-05-30       Impact factor: 3.162

10.  Different Functions of Phylogenetically Distinct Bacterial Complex I Isozymes.

Authors:  Melanie A Spero; Joshua R Brickner; Jordan T Mollet; Tippapha Pisithkul; Daniel Amador-Noguez; Timothy J Donohue
Journal:  J Bacteriol       Date:  2016-03-31       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.